---
schema_version: "secwatch.filing_event.v1"
accession: "0001764046-26-000085"
form_type: "8-K"
ticker: "CLVT"
cik: "0001764046"
company_name: "CLARIVATE PLC"
filed_at: "2026-07-06T10:01:11+00:00"
generated_at: "2026-07-06T10:05:23.506051+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Clarivate sells Life Sciences & Healthcare segment to Altaris for $600M

## Summary
- Deal value $600M: $500M cash at close, $25M deferred cash, $75M seller note.
- Proceeds to reduce debt; transaction expected to close by end of 2026.
- Reaffirms FY2026 outlook; LS&H to be classified as discontinued ops from Q3.
- Expects non-cash goodwill impairment of $225-250M on LS&H segment.
- Company sharpens focus on Academia & Government and Intellectual Property segments.

## SEC filing metadata
- accession: 0001764046-26-000085
- form_type: 8-K
- ticker: CLVT
- cik: 0001764046
- company_name: CLARIVATE PLC
- filed_at: 2026-07-06T10:01:11+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/0001764046-26-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/clvt-20260706.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764046-26-000085
- JSON: https://secwatch.observer/filing/0001764046-26-000085.json
- Plain text: https://secwatch.observer/filing/0001764046-26-000085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.